Schuttelaar ML - Search Results

1

Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.

Gabes M, Ragamin A, Baker A, Kann G, Donhauser T, Gabes D, Howells L, Thomas KS, Oosterhaven JAF, Pasmans SGMA, Schuttelaar ML, Apfelbacher C. Gabes M, et al. Among authors: schuttelaar ml. Br J Dermatol. 2022 Dec;187(6):919-926. doi: 10.1111/bjd.21767. Epub 2022 Aug 19. Br J Dermatol. 2022. PMID: 35842231

2

Guideline for translation and national validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).

Oosterhaven JAF, Schuttelaar MLA, Apfelbacher C, Diepgen TL, Ofenloch RF. Oosterhaven JAF, et al. Contact Dermatitis. 2017 Aug;77(2):106-115. doi: 10.1111/cod.12788. Epub 2017 May 8. Contact Dermatitis. 2017. PMID: 28481015

3

Presenteeism in a Dutch hand eczema population-a cross-sectional survey.

Oosterhaven JAF, Flach PA, Bültmann U, Schuttelaar MLA. Oosterhaven JAF, et al. Contact Dermatitis. 2018 Jul;79(1):10-19. doi: 10.1111/cod.12993. Epub 2018 Apr 1. Contact Dermatitis. 2018. PMID: 29607512 Free PMC article.

4

Dupilumab Treatment of Very Severe Refractory Atopic Hand Eczema.

Oosterhaven JAF, Romeijn GLE, Schuttelaar MLA. Oosterhaven JAF, et al. JAMA Dermatol. 2018 Aug 1;154(8):969-970. doi: 10.1001/jamadermatol.2018.2027. JAMA Dermatol. 2018. PMID: 29971331 No abstract available.

5

Which outcomes have been measured in hand eczema trials? A systematic review.

Rönsch H, Apfelbacher C, Brans R, Matterne U, Molin S, Ofenloch R, Oosterhaven JAF, Schuttelaar MLA, Weisshaar E, Yew YW, Bauer A. Rönsch H, et al. Contact Dermatitis. 2019 Apr;80(4):201-207. doi: 10.1111/cod.13212. Epub 2019 Feb 22. Contact Dermatitis. 2019. PMID: 30632613

6

[Ocular symptoms associated with dupilumab in atopic dermatitis].

Voorberg AN, Oosterhaven JAF, Wijdh RHJ, de Bruin-Weller MS, Schuttelaar MLA. Voorberg AN, et al. Ned Tijdschr Geneeskd. 2019 Mar 21;163:D3227. Ned Tijdschr Geneeskd. 2019. PMID: 30945835 Dutch.

7

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.

Oosterhaven JAF, Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. Oosterhaven JAF, et al. J Dermatol. 2019 Aug;46(8):680-685. doi: 10.1111/1346-8138.14982. Epub 2019 Jun 12. J Dermatol. 2019. PMID: 31187925 Free PMC article.

8

Interpretability of the Quality Of Life in Hand Eczema Questionnaire.

Oosterhaven JAF, Ofenloch RF, Schuttelaar MLA. Oosterhaven JAF, et al. J Invest Dermatol. 2020 Apr;140(4):785-790. doi: 10.1016/j.jid.2019.08.450. Epub 2019 Oct 10. J Invest Dermatol. 2020. PMID: 31606350 Free article.

9

The value of ongoing surveillance on the prevalence of contact sensitization.

Schuttelaar MLA. Schuttelaar MLA. Br J Dermatol. 2020 Nov;183(5):800-801. doi: 10.1111/bjd.19153. Epub 2020 May 26. Br J Dermatol. 2020. PMID: 32458421 Free PMC article.

10

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.

Oosterhaven JAF, Spekhorst LS, Zhang J, Voorberg AN, Romeijn GLE, Boesjes CM, de Graaf M, de Bruin-Weller MS, Schuttelaar MLA. Oosterhaven JAF, et al. J Dermatolog Treat. 2022 Jun;33(4):1986-1989. doi: 10.1080/09546634.2021.1937485. Epub 2021 Jun 21. J Dermatolog Treat. 2022. PMID: 34151695 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters